SS Innovations International, Inc.

SS Innovations International, Inc. develops, manufactures, and sells the SSi Mantra surgical robotic system and related SSi Mudra instruments and accessories. The company is based in the United States but its manufacturing and commercial footprint is centered in India, with sales and support activities extending into selected international markets.

−16,8 %

46,0 %

−28,5 %

+105,7 %

1.86

1.21

— SS Innovations International, Inc.
%
Surgical robotic systems90% The SSi Mantra robotic platform sold to hospitals and surgical centers.
Instruments and accessories7% Reusable and consumable instruments, accessories, and stocking orders for installed systems.
Warranty and service revenue2% Warranty coverage, readiness support, maintenance plans, and technical support services.
Lease and pay-per-procedure income1% Recurring income from systems placed under usage-based or deferred commercial models.

Customers are hospitals, surgical centers, and physicians that acquire robotic surgery systems for use in urology,...

  • Hospitals and surgical centersprimary

    Buy SSi Mantra systems for operating room use across multiple specialties and to build robotic surgery programs.

  • Physicians and surgical teamssecondary

    Use the platform and buy into training, proctoring, and support services to adopt robotic procedures.

  • Installed-base customersprimary

    Reorder instruments, accessories, warranty coverage, and maintenance services after system installation.

  • Usage-based customerssecondary

    Adopt pay-per-procedure or deferred models to access the system with lower upfront capital needs.

Substantially all reported sales have been in India, with additional individual sales in the United Arab Emirates,...

  • •India is the core commercial market and installed-base center
  • •Manufacturing operations are based in India
  • •Sales have also been made in the UAE, Ecuador, Iraq, and Nepal
  • •Additional sales have been made in Colombia, Indonesia, and the Philippines
  • •Global distributors and field service engineers support international rollout

The company’s strategy is to expand access to surgical robotics by offering a lower-cost, next-generation system with...

01
Expand installed base of SSi Mantramedium-term

A larger installed base supports system sales, instrument pull-through, and service revenue.

02
Increase recurring revenue mixmedium-term

Instruments, accessories, warranty, and service plans create repeat revenue after system placement.

03
Broaden product portfoliomedium-term

New instruments and specialty applications increase the number of procedures the platform can support.

04
Expand regulatory and market accesslong-term

Approvals are needed to sell in regulated markets and to scale beyond current geographies.

The business depends on continued adoption of a relatively new robotic platform, successful regulatory approvals, and...

high

Regulatory approval delays or denials

Sales in regulated markets depend on obtaining and maintaining approvals for the robotic system and related devices.

Scope
International expansion
Materiality
high
high

Financing and liquidity dependence

The company has relied on debt and equity offerings and may need additional capital to fund operations and expansion.

Scope
Corporate funding
Materiality
high
high

Geographic concentration in India

Substantially all sales have been in India, so demand or policy changes there would affect results disproportionately.

Scope
India
Materiality
high
medium

Commercial adoption risk

Robotic surgery adoption depends on surgeon acceptance, hospital budgets, and willingness to switch from established systems.

Scope
System sales
Materiality
high
medium

Manufacturing and service execution risk

The model requires reliable production, installation, maintenance, and technical support to protect customer uptime.

Scope
India operations and distributor network
Materiality
medium
Revenue recognition for mixed commercial models
System sales, lease income, and recurring service revenue
Standalone selling price allocation
Reported mix and timing of revenue
Stock-based compensation
Operating expenses and net loss
Going-concern and financing assumptions
Liquidity disclosures and investor risk assessment

SHOULDER INNOVATIONS, INC.

SI · Surgical & Medical Instruments & Apparatus

INTUITIVE SURGICAL INC

ISRG · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Vicarious Surgical Inc.

RBOT · Orthopedic, Prosthetic & Surgical Appliances & Supplies

SS&C Technologies Holdings Inc

SSNC · Services-Prepackaged Software

STRYKER CORP

SYK · Surgical & Medical Instruments & Apparatus

Stereotaxis, Inc.

STXS · Electromedical & Electrotherapeutic Apparatus

: 29/04/2026